PMID: 336378Oct 14, 1977Paper

Controlled trial of acebutolol in hypertension

European Journal of Clinical Pharmacology
L HanssonM Holm

Abstract

Acebutolol, a new cardioselective beta-adrenoceptor blocking agent, has been evaluated for the treatment of hypertension. Thirty eight previously untreated male patients with essential hypertension received placebo treatment during a 4-week run-in period, and then they were randomly (double-bind) allocated either to continued placebo treatment for three 4-week periods or to treatment with acebutolol 400, 600, and 1200 mg daily, respectively, for three 4-week periods. Blood pressure and heart rate were recorded at the end of each 4-week period. Treatment with acebutolol produced statistically significant reductions in blood pressure and heart rate as compared to the placebo regimen.

References

May 17, 1975·British Medical Journal·L HanssonA Westerlund
Jun 1, 1973·British Journal of Pharmacology·B BasilD R Maxwell
Apr 1, 1972·Klinische Wochenschrift·L HanssonB Hood
Jun 29, 1974·British Medical Journal·E C Huskisson, J A Wojtulewski
Jun 1, 1972·American Heart Journal·F J ZachariasB G Wall
Jan 4, 1969·British Medical Journal·B N Prichard, P M Gillam
Mar 1, 1964·Clinical Pharmacology and Therapeutics·G SCHROEDER, L WERKOE
Sep 19, 1964·British Medical Journal·B N PRICHARD, P M GILLAM

❮ Previous
Next ❯

Citations

Jan 1, 1980·European Journal of Clinical Pharmacology·M ThibonnierP Corvol
Dec 18, 1978·European Journal of Clinical Pharmacology·M A MartinA J Smith
Jan 1, 1980·Pharmacology & Therapeutics·B N Prichard, C W Owens
May 1, 1985·American Heart Journal·G De BonoA J Summers
Mar 1, 1984·The American Journal of Cardiology·B TrimarcoM Condorelli
Feb 1, 1982·British Journal of Clinical Pharmacology·P A MitenkoJ J Brossard
Nov 28, 2014·The Cochrane Database of Systematic Reviews·Gavin W K WongJames M Wright
Apr 1, 1982·British Journal of Clinical Pharmacology·M ThibonnierJ Menard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.